Beam Therapeutics Inc. (BEAM) Social Stream
BEAM THERAPEUTICS INC (BEAM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BEAM THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 10 | $150 | $85 | $124.333 | $32.4 | 283.74% |
| 2021-12-22 | 10 | $150 | $85 | $121.555 | $32.4 | 275.17% |
| 2022-01-05 | 11 | $150 | $85 | $122.4 | $32.4 | 277.78% |
| 2022-01-10 | 11 | $159 | $85 | $124.5 | $32.4 | 284.26% |
| 2022-02-01 | 9 | $159 | $85 | $122.222 | $32.4 | 277.23% |
| 2022-02-28 | 10 | $159 | $85 | $126.25 | $32.4 | 289.66% |
| 2022-03-01 | 9 | $154 | $110 | $130.285 | $32.4 | 302.11% |
| 2022-05-09 | 8 | $154 | $110 | $130.285 | $32.4 | 302.11% |
| 2022-05-10 | 8 | $154 | $75 | $114.142 | $32.4 | 252.29% |
| 2022-05-11 | 8 | $130 | $75 | $110 | $32.4 | 239.51% |
| 2022-06-08 | 8 | $130 | $75 | $103.142 | $32.4 | 218.34% |
| 2022-06-17 | 9 | $130 | $41 | $95.375 | $32.4 | 194.37% |
| 2022-07-18 | 9 | $130 | $61 | $97.875 | $32.4 | 202.08% |
| 2022-08-10 | 10 | $130 | $61 | $97.875 | $32.4 | 202.08% |
| 2022-09-17 | 10 | $130 | $60 | $90.125 | $32.4 | 178.16% |
| 2022-11-07 | 10 | $130 | $60 | $89.222 | $32.4 | 175.38% |
| 2022-11-08 | 11 | $130 | $60 | $84.666 | $32.4 | 161.31% |
| 2022-12-13 | 11 | $130 | $60 | $82.4 | $32.4 | 154.32% |
| 2022-12-20 | 11 | $130 | $60 | $82.9 | $32.4 | 155.86% |
| 2023-01-06 | 10 | $103 | $60 | $77.222 | $32.4 | 138.34% |
| 2023-01-26 | 10 | $103 | $60 | $76.777 | $32.4 | 136.97% |
| 2023-02-01 | 11 | $103 | $60 | $75.3 | $32.4 | 132.41% |
| 2023-02-08 | 11 | $103 | $60 | $74.3 | $32.4 | 129.32% |
| 2023-03-01 | 12 | $103 | $60 | $74.1 | $32.4 | 128.7% |
| 2023-03-02 | 12 | $105 | $60 | $74.727 | $32.4 | 130.64% |
The Trend in the Analyst Price Target
BEAM's average price target has moved down $44.44 over the prior 18 months.
BEAM reports an average of 108.73% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-18 | 9 | 130 | 61 | 97.875 | 58.01 | 68.72% |
| 2022-12-13 | 11 | 130 | 60 | 82.400 | 45.74 | 80.15% |
| 2023-01-26 | 10 | 103 | 60 | 76.777 | 43.85 | 75.09% |
| 2023-02-01 | 11 | 103 | 60 | 75.300 | 45.97 | 63.8% |
| 2023-03-02 | 12 | 105 | 60 | 74.727 | 38.81 | 92.55% |
BEAM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 10 | 0 | 2 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
Over the past 22 months, BEAM's average broker recommendation rating improved by 0.79.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, BEAM THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2939.81% of them.
- BEAM has a greater average analyst price target than 3000.34% of stocks in the mid market cap category.
- BEAM THERAPEUTICS INC's number of analysts covering the stock is higher than 2638.04% of stocks in the mid market cap category.
- In terms of how BEAM THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -2259.44% of that group.
Stocks similar to BEAM THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VIR, SWTX, and IMVT.
View All Top Stocks by Price Target
Is BEAM a Buy, Hold or Sell? See the POWR Ratings now!